Literature DB >> 4978447

A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects.

D Seidel, P Alaupovic, R H Furman.   

Abstract

Three immunochemically and electrophoretically distinct lipoproteins, LP-A, LP-B, and LP-X,(1) were isolated from the low density lipoprotein fraction (1.006-1.063 g/ml) in plasma from patients with biliary obstruction by a separation procedure which combines ultracentrifugation, heparin precipitation, and ethanol fractionation. This method, here described, permits the quantitative determination of individual plasma lipoprotein families on the basis of their protein moieties, rather than on the basis of their lipid moieties or density. The chemical composition of the unique lipoprotein, LP-X, was similar to that of an abnormal lipoprotein, OLP, isolated by Russ et al. (29) and by Switzer (30). In obstructive jaundice plasma, the combined LP-X and LP-B accounted for 98% and the LP-A for only 2% of the total protein content of the LDL fraction. This study indicates that the plasma lipoprotein pattern in obstructive jaundice is characterized by (a) a decreased concentration of HDL, (b) an increased concentration of LDL, and (c) the presence in the LDL fraction of varying amounts of a specific lipoprotein, LP-X, immunochemically and chemically distinct from LP-A and LP-B. LP-X, with its characteristically high content of unesterified cholesterol and phospholipids, is primarily responsible for the unusual protein and lipid content of the LDL fraction. Screening tests in 61 patients with various forms of jaundice indicated that a characteristic immunoelectrophoretic precipitin are between plasma samples and purified antibodies to LP-X was observed only in patients with obstructive jaundice. This simple immunochemical test may represent a valuable new tool in the differential diagnosis of obstructive and nonobstructive jaundice.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978447      PMCID: PMC322342          DOI: 10.1172/JCI106085

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  [A SIMPLE METHOD FOR MICRODETERMINATION OF PHOSPHATE IN PAPER CHROMATOGRAPHY].

Authors:  E GERLACH; B DEUTICKE
Journal:  Biochem Z       Date:  1963-07-26

2.  [On a rapid determination of the cholesterol bound to the serum alpha- and beta-lipoproteins].

Authors:  M BURSTEIN; J SAMAILLE
Journal:  Clin Chim Acta       Date:  1960-07       Impact factor: 3.786

3.  Ultracentrifugal characterization of the lipoprotein spectrum in obstructive jaundice: studies of serum lipid relationships in intra-and extrahepatic biliary obstruction.

Authors:  R H FURMAN; L L CONRAD
Journal:  J Clin Invest       Date:  1957-05       Impact factor: 14.808

4.  THE LIPIDS OF SERUM AND LIVER IN PATIENTS WITH HEPATIC DISEASES.

Authors:  E B Man; B L Kartin; S H Durlacher; J P Peters
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

5.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

6.  The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis.

Authors:  H G KUNKEL; E H AHRENS
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

7.  The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis.

Authors:  E H AHRENS; H G KUNKEL
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808

8.  Lipoproteins and xanthomatous diseases.

Authors:  J McGINLEY; H JONES; J GOFMAN
Journal:  J Invest Dermatol       Date:  1952-07       Impact factor: 8.551

9.  Lipogenic hypercholesteremia. A guide for reorientation in the consideration of lipid-cholesterol relationships.

Authors:  M Friedman; S O Byers; R H Rosenman
Journal:  Arch Intern Med       Date:  1965-12

10.  Biosynthesis of lipoprotein by rat intestinal mucosa.

Authors:  F T Hatch; Y Aso; L M Hagopian; J J Rubenstein
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157

View more
  49 in total

1.  Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures.

Authors:  A Suenram; W J McConathy; P Alaupovic
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

Review 2.  The hypercholesterolaemia of obstructive jaundice.

Authors:  N McIntyre; D S Harry; A J Pearson
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

3.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

4.  Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Authors:  Lita A Freeman; Robert D Shamburek; Maureen L Sampson; Edward B Neufeld; Masaki Sato; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Lipid Res       Date:  2019-02-26       Impact factor: 5.922

5.  38-year-old woman with abnormal liver enzymes and hyperlipidemia.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Mayo Clin Proc       Date:  2009-06       Impact factor: 7.616

6.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

7.  Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis.

Authors:  L A Turnberg; M P Mahoney; M H Gleeson; C B Freeman; A H Gowenlock
Journal:  Gut       Date:  1972-12       Impact factor: 23.059

8.  Formation of lipoprotein-X. Its relationship to bile compounds.

Authors:  E Manzato; R Fellin; G Baggio; S Walch; W Neubeck; D Seidel
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 9.  Plasma lipids and lipoproteins in liver disease.

Authors:  N McIntyre
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

10.  Changes in high density lipoproteins in patients with hepatobiliary diseases. Levels and lipid composition of HDL2 and HDL3 and LCAT reaction.

Authors:  G Kajiyama; K Takata; I Horiuchi; M Nakagawa; M Yamamoto; A Miyoshi
Journal:  Gastroenterol Jpn       Date:  1983-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.